title: Guillain-Barré syndrome after septicemia following clozapine-induced agranulocytosis. A case report.
abstract: We report the case of a patient with schizophrenia, who experienced agranulocytosis during clozapine treatment, followed by bronchopulmonal infection and Guillain-Barré syndrome. The case was recorded within the German surveillance project "drug safety in psychiatry" (AMSP).
authors.forename: J
authors.initials: J
authors.lastname: Mobascher
authors.forename: J
authors.initials: J
authors.lastname: Zielasek
authors.forename: F J
authors.initials: FJ
authors.lastname: Schuier
authors.forename: A
authors.initials: A
authors.lastname: Mobascher
authors.forename: R
authors.initials: R
authors.lastname: Grohmann
authors.forename: M W
authors.initials: MW
authors.lastname: Agelink
authors.forename: J
authors.initials: J
authors.lastname: Cordes
mesh_terms: D000380:Agranulocytosis / Q000139:chemically induced* / Q000150:complications*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D020275:Guillain-Barre Syndrome / Q000209:etiology*; D006801:Humans; D008875:Middle Aged; D011595:Psychomotor Agitation / Q000150:complications; D012141:Respiratory Tract Infections / Q000150:complications / Q000209:etiology; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D018805:Sepsis / Q000150:complications* / Q000209:etiology*
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine